Phibro Animal Health Corp...
20.30
0.03 (0.15%)
At close: Jan 14, 2025, 3:59 PM
20.28
-0.10%
After-hours Jan 14, 2025, 04:00 PM EST

Phibro Animal Health Corporation Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Vaccines Revenue 32.03M 31.99M 32.92M 29.73M 26.22M 26.20M 22.77M 23.02M
Vaccines Revenue Growth +0.14% -2.85% +10.75% +13.39% +0.06% +15.08% -1.07% n/a

Revenue by Geography

Quarter Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018Jun 30, 2017Jun 30, 2016Jun 30, 2015Jun 30, 2014
Asia Pacific Revenue 63.23M 61.45M 66.93M 58.01M 57.30M 90.15M 51.41M 50.48M 46.44M 43.22M 43.42M
Asia Pacific Revenue Growth +2.89% -8.18% +15.39% +1.23% -36.44% +75.37% +1.83% +8.72% +7.45% -0.48% n/a
Emea Revenue 121.98M 117.81M 122.48M n/a n/a 480.10M 494.60M 484.15M 473.25M 475.94M 435.41M
Emea Revenue Growth +3.53% -3.81% n/a n/a n/a -2.93% +2.16% +2.30% -0.57% +9.31% n/a
Latin America And Canada Revenue 247.71M 219.85M 191.05M n/a n/a n/a n/a n/a n/a n/a n/a
Latin America And Canada Revenue Growth +12.67% +15.07% n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 584.76M 578.77M 561.80M n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue Growth +1.03% +3.02% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 65.80M 74.14M 58.68M 62.91M 68.50M 52.90M 57.00M 61.54M 54.96M 55.50M 52.43M 48.38M 50.07M 50.70M 49.03M 48.38M 48.43M 42.40M 48.23M 49.49M 47.52M 53.20M 42.30M 42.94M 42.95M 41.40M 42.58M 42.98M 40.99M 39.60M 30.65M 40.87M 39.19M 39.50M 38.78M 39.80M 38.30M 39.88M 37.30M
Selling, General, and Administrative Revenue Growth -11.25% +26.34% -6.73% -8.15% +29.49% -7.19% -7.38% +11.97% -0.97% +5.85% +8.38% -3.37% -1.25% +3.40% +1.36% -0.12% +14.22% -12.09% -2.55% +4.16% -10.68% +25.76% -1.48% -0.03% +3.75% -2.76% -0.94% +4.84% +3.52% +29.22% -25.02% +4.30% -0.79% +1.85% -2.54% +3.90% -3.97% +6.94% n/a
Research and Development Revenue n/a 29.19M n/a n/a n/a 24.39M n/a n/a n/a 20.83M n/a n/a n/a 17.76M n/a n/a n/a 13.74M n/a n/a n/a 12.09M n/a n/a n/a 10.00M n/a n/a n/a 11.02M n/a n/a n/a 11.03M n/a n/a n/a 9.51M n/a
Research and Development Revenue Growth -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a n/a -100.00% n/a n/a

Create Price Alert on PAHC

Your price alert will notify you when the stock price is above 20.30.

Add to Watchlist